Sellas Life Sciences | D:发行公告
Sellas Life Sciences | SC 13G:超过5%持股股东披露文件-Highbridge Capital Management, LLC(6.5%)
Sellas Life Sciences | 4:持股变动声明-高管 Stergiou Angelos M.
Sellas Life Sciences | 4:持股变动声明-董事 SCHEINBERG DAVID A
Sellas Life Sciences | 4:持股变动声明-高管 WOOD BARBARA A
Sellas Life Sciences | 4:持股变动声明-高管 Burns John Thomas
Sellas Life Sciences | 4:持股变动声明-董事 VAN NOSTRAND ROBERT L
Sellas Life Sciences | 4:持股变动声明-董事 Varian John
Sellas Life Sciences | 4:持股变动声明-高管 Francomano Robert
Sellas Life Sciences | 4:持股变动声明-董事 Wasman Jane
Sellas Life Sciences | 4:持股变动声明-董事 Kalin Katherine Bach
Sellas Life Sciences | 4:持股变动声明-高管 WOOD BARBARA A
Sellas Life Sciences | 4:持股变动声明-高管 Stergiou Angelos M.
Sellas Life Sciences | 4:持股变动声明-首席商务官 Francomano Robert
Sellas Life Sciences | 4:持股变动声明-首席财务官 Burns John Thomas
Sellas Life Sciences | 4:持股变动声明
Sellas Life Sciences | 4:持股变动声明
Sellas Life Sciences | 4:持股变动声明
Sellas Life Sciences | 4:持股变动声明
Sellas Life Sciences | 4:持股变动声明
暂无数据